Gremlin, a Bone Morphogenetic Protein Antagonist, Is a Crucial Angiogenic Factor in Pituitary Adenoma

Gremlin is an antagonist of bone morphogenetic protein (BMP) and a major driving force in skeletal modeling in the fetal stage. Several recent reports have shown that Gremlin is also involved in angiogenesis of lung cancer and diabetic retinopathy. The purpose of this study was to investigate the ro...

Full description

Saved in:
Bibliographic Details
Main Authors: Kenta Koketsu, Daizo Yoshida, Kyongsong Kim, Yudo Ishii, Shigeyuki Tahara, Akira Teramoto, Akio Morita
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:International Journal of Endocrinology
Online Access:http://dx.doi.org/10.1155/2015/834137
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832560846811693056
author Kenta Koketsu
Daizo Yoshida
Kyongsong Kim
Yudo Ishii
Shigeyuki Tahara
Akira Teramoto
Akio Morita
author_facet Kenta Koketsu
Daizo Yoshida
Kyongsong Kim
Yudo Ishii
Shigeyuki Tahara
Akira Teramoto
Akio Morita
author_sort Kenta Koketsu
collection DOAJ
description Gremlin is an antagonist of bone morphogenetic protein (BMP) and a major driving force in skeletal modeling in the fetal stage. Several recent reports have shown that Gremlin is also involved in angiogenesis of lung cancer and diabetic retinopathy. The purpose of this study was to investigate the role of Gremlin in tumor angiogenesis in pituitary adenoma. Double fluorescence immunohistochemistry of Gremlin and CD34 was performed in pituitary adenoma tissues obtained during transsphenoidal surgery in 45 cases (7 PRLoma, 17 GHoma, 2 ACTHoma, and 2 TSHoma). Gremlin and microvascular density (MVD) were detected by double-immunofluorescence microscopy in CD34-positive vessels from tissue microarray analysis of 60 cases of pituitary adenomas (6 PRLoma, 23 GHoma, 22 NFoma, 5 ACTHoma, and 4 TSHoma). In tissue microarray analysis, MVD was significantly correlated with an increased Gremlin level (linear regression: P<0.005,  r2=0.4958). In contrast, Gremlin expression showed no correlation with tumor subtype or Knosp score. The high level of expression of Gremlin in pituitary adenoma tissue with many CD34-positive vessels and the strong coherence of these regions indicate that Gremlin is associated with angiogenesis in pituitary adenoma cells.
format Article
id doaj-art-f89174c257e04281bf0143ff44427133
institution Kabale University
issn 1687-8337
1687-8345
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series International Journal of Endocrinology
spelling doaj-art-f89174c257e04281bf0143ff444271332025-02-03T01:26:35ZengWileyInternational Journal of Endocrinology1687-83371687-83452015-01-01201510.1155/2015/834137834137Gremlin, a Bone Morphogenetic Protein Antagonist, Is a Crucial Angiogenic Factor in Pituitary AdenomaKenta Koketsu0Daizo Yoshida1Kyongsong Kim2Yudo Ishii3Shigeyuki Tahara4Akira Teramoto5Akio Morita6Department of Neurosurgery, Nippon Medical School, Tokyo 113-8602, JapanDepartment of Neurosurgery, Nippon Medical School, Tokyo 113-8602, JapanDepartment of Neurosurgery, Nippon Medical School, Tokyo 113-8602, JapanDepartment of Neurosurgery, Nippon Medical School, Tokyo 113-8602, JapanDepartment of Neurosurgery, Nippon Medical School, Tokyo 113-8602, JapanDepartment of Neurosurgery, Nippon Medical School, Tokyo 113-8602, JapanDepartment of Neurosurgery, Nippon Medical School, Tokyo 113-8602, JapanGremlin is an antagonist of bone morphogenetic protein (BMP) and a major driving force in skeletal modeling in the fetal stage. Several recent reports have shown that Gremlin is also involved in angiogenesis of lung cancer and diabetic retinopathy. The purpose of this study was to investigate the role of Gremlin in tumor angiogenesis in pituitary adenoma. Double fluorescence immunohistochemistry of Gremlin and CD34 was performed in pituitary adenoma tissues obtained during transsphenoidal surgery in 45 cases (7 PRLoma, 17 GHoma, 2 ACTHoma, and 2 TSHoma). Gremlin and microvascular density (MVD) were detected by double-immunofluorescence microscopy in CD34-positive vessels from tissue microarray analysis of 60 cases of pituitary adenomas (6 PRLoma, 23 GHoma, 22 NFoma, 5 ACTHoma, and 4 TSHoma). In tissue microarray analysis, MVD was significantly correlated with an increased Gremlin level (linear regression: P<0.005,  r2=0.4958). In contrast, Gremlin expression showed no correlation with tumor subtype or Knosp score. The high level of expression of Gremlin in pituitary adenoma tissue with many CD34-positive vessels and the strong coherence of these regions indicate that Gremlin is associated with angiogenesis in pituitary adenoma cells.http://dx.doi.org/10.1155/2015/834137
spellingShingle Kenta Koketsu
Daizo Yoshida
Kyongsong Kim
Yudo Ishii
Shigeyuki Tahara
Akira Teramoto
Akio Morita
Gremlin, a Bone Morphogenetic Protein Antagonist, Is a Crucial Angiogenic Factor in Pituitary Adenoma
International Journal of Endocrinology
title Gremlin, a Bone Morphogenetic Protein Antagonist, Is a Crucial Angiogenic Factor in Pituitary Adenoma
title_full Gremlin, a Bone Morphogenetic Protein Antagonist, Is a Crucial Angiogenic Factor in Pituitary Adenoma
title_fullStr Gremlin, a Bone Morphogenetic Protein Antagonist, Is a Crucial Angiogenic Factor in Pituitary Adenoma
title_full_unstemmed Gremlin, a Bone Morphogenetic Protein Antagonist, Is a Crucial Angiogenic Factor in Pituitary Adenoma
title_short Gremlin, a Bone Morphogenetic Protein Antagonist, Is a Crucial Angiogenic Factor in Pituitary Adenoma
title_sort gremlin a bone morphogenetic protein antagonist is a crucial angiogenic factor in pituitary adenoma
url http://dx.doi.org/10.1155/2015/834137
work_keys_str_mv AT kentakoketsu gremlinabonemorphogeneticproteinantagonistisacrucialangiogenicfactorinpituitaryadenoma
AT daizoyoshida gremlinabonemorphogeneticproteinantagonistisacrucialangiogenicfactorinpituitaryadenoma
AT kyongsongkim gremlinabonemorphogeneticproteinantagonistisacrucialangiogenicfactorinpituitaryadenoma
AT yudoishii gremlinabonemorphogeneticproteinantagonistisacrucialangiogenicfactorinpituitaryadenoma
AT shigeyukitahara gremlinabonemorphogeneticproteinantagonistisacrucialangiogenicfactorinpituitaryadenoma
AT akirateramoto gremlinabonemorphogeneticproteinantagonistisacrucialangiogenicfactorinpituitaryadenoma
AT akiomorita gremlinabonemorphogeneticproteinantagonistisacrucialangiogenicfactorinpituitaryadenoma